Literature DB >> 14712485

Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma.

Christian Hartmann1, Astrid Nümann, Wolf Mueller, Nikola Holtkamp, Matthias Simon, Andreas von Deimling.   

Abstract

Astrocytomas and glioblastomas are the most frequent primary brain tumors in adults. Mutations and altered expression of multiple genes have been found to contribute to the genesis of these tumors. However, many factors in the genesis of astrocytic gliomas are not resolved yet. The frequent losses on several chromosomes indicate the role of still unidentified tumor suppressor genes. Loss of heterozygosity (LOH) on 22q has been described in up to 30% of astrocytic tumors and may be associated with progression to anaplasia. In a first step, information from the nearly finished physical sequence of chromosome 22 were used to map LOH data from 22q deletion studies on different tumor entities to identify potential tumor suppressor gene candidate regions. Next, a series of 153 astrocytic gliomas was examined with 11 polymorphic markers spanning these regions. Forty-nine (32%) astrocytic gliomas exhibited LOH on 22q, 17 (35%) of which lost heterozygosity for all markers and 32 (65%) of which carried interstitial or partial deletions. Two regions were identified on the physical DNA sequence. The centromeric region spans 3 Mb and the telomeric region 2.7 Mb. The reduced size of these regions now allows direct analysis of all genes included. We already performed mutation analysis on 4 candidate genes from these regions (MYO18B, DJ1042K10.2, MKL1 and EP300), but did not find any mutations in astrocytic tumors. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14712485     DOI: 10.1002/ijc.11638

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Loss of 22q chromosome is related to glioma progression and loss of 10q.

Authors:  Florence Laigle-Donadey; Emmanuelle Crinière; Alexandra Benouaich; Emmanuelle Lesueur; Karima Mokhtari; Khe Hoang-Xuan; Marc Sanson
Journal:  J Neurooncol       Date:  2006-02       Impact factor: 4.130

2.  Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3.

Authors:  Blanca Suarez-Merino; Mike Hubank; Tamas Revesz; William Harkness; Richard Hayward; Dominic Thompson; John L Darling; David G T Thomas; Tracy J Warr
Journal:  Neuro Oncol       Date:  2005-01       Impact factor: 12.300

3.  Molecular Analysis of Pediatric Oligodendrogliomas Highlights Genetic Differences with Adult Counterparts and Other Pediatric Gliomas.

Authors:  David Nauen; Lisa Haley; Ming-Tseh Lin; Arie Perry; Caterina Giannini; Peter C Burger; Fausto J Rodriguez
Journal:  Brain Pathol       Date:  2015-08-14       Impact factor: 6.508

4.  Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness.

Authors:  M Schulze; O Fedorchenko; T G Zink; C B Knobbe-Thomsen; S Kraus; S Schwinn; A Beilhack; G Reifenberger; C M Monoranu; A-L Sirén; E Jeanclos; A Gohla
Journal:  Oncogene       Date:  2015-11-09       Impact factor: 9.867

5.  Systematic and Multi-Omics Prognostic Analysis of Lysine Acetylation Regulators in Glioma.

Authors:  Zewei Tu; Lei Wu; Haitao Luo; Jingying Li; Shigang Lv; Minhua Ye; Feng Liu; Chuming Tao; Xingen Zhu; Kai Huang
Journal:  Front Mol Biosci       Date:  2021-02-26

6.  Impaired Pten expression in human malignant peripheral nerve sheath tumours.

Authors:  Maren Bradtmöller; Christian Hartmann; Jan Zietsch; Sebastian Jäschke; Victor-F Mautner; Andreas Kurtz; Su-Jin Park; Michael Baier; Anja Harder; David Reuss; Andreas von Deimling; Frank L Heppner; Nikola Holtkamp
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.